同和药业：取得专利证书，发明名称“一种瑞美吉泮中间体的制备方法”

Core Viewpoint - Tonghe Pharmaceutical (SZ 300636, closing price: 8.77 yuan) announced on August 4 that it has received an invention patent certificate from the National Intellectual Property Administration for a method of preparing the intermediate of Remogliflozin [2] Company Summary - The patent is titled "A Preparation Method for an Intermediate of Remogliflozin" [2]